{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:35:59Z","timestamp":1778895359890,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370548"],"award-info":[{"award-number":["81370548"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","award":["2014ZYJB0202"],"award-info":[{"award-number":["2014ZYJB0202"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.clinre.2016.11.010","type":"journal-article","created":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T17:32:17Z","timestamp":1483119137000},"page":"303-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Intrahepatic upregulation of MRTF-A signaling contributes to increased hepatic vascular resistance in cirrhotic rats with portal hypertension"],"prefix":"10.1016","volume":"41","author":[{"given":"Lei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longci","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensheng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clinre.2016.11.010_bib0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cld.2013.12.001","article-title":"Pathophysiology of portal hypertension","volume":"18","author":"Iwakiri","year":"2014","journal-title":"Clin Liver Dis"},{"issue":"9","key":"10.1016\/j.clinre.2016.11.010_bib0165","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/gut.2005.081059","article-title":"Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis","volume":"55","author":"Zhou","year":"2006","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.clinre.2016.11.010_bib0170","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.27343","article-title":"Molecular pathophysiology of portal hypertension","volume":"61","author":"Fernandez","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2016.11.010_bib0175","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/01.MIB.0000437615.98881.31","article-title":"Novel Rho\/MRTF\/SRF inhibitors block matrix-stiffness and TGF-beta-induced fibrogenesis in human colonic myofibroblasts","volume":"20","author":"Johnson","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinre.2016.11.010_bib0180","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.yjmcc.2015.02.010","article-title":"A crosstalk between chromatin remodeling and histone H3K4 methyltransferase complexes in endothelial cells regulates angiotensin II-induced cardiac hypertrophy","volume":"82","author":"Weng","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.clinre.2016.11.010_bib0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yjmcc.2014.11.009","article-title":"Endothelial MRTF-A mediates angiotensin II induced cardiac hypertrophy","volume":"80","author":"Weng","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.clinre.2016.11.010_bib0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biocel.2015.12.005","article-title":"Myocardin-related transcription factor A (MRTF-A) plays an essential role in hepatic stellate cell activation by epigenetically modulating TGF-beta signaling","volume":"71","author":"Tian","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"10.1016\/j.clinre.2016.11.010_bib0195","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/CIRCRESAHA.110.223172","article-title":"Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction","volume":"107","author":"Small","year":"2010","journal-title":"Circ Res"},{"issue":"51","key":"10.1016\/j.clinre.2016.11.010_bib0200","doi-asserted-by":"crossref","first-page":"44116","DOI":"10.1074\/jbc.M111.276931","article-title":"Myocardin-related transcription factor-A complexes activate type I collagen expression in lung fibroblasts","volume":"286","author":"Luchsinger","year":"2011","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.clinre.2016.11.010_bib0205","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/CIRCRESAHA.111.240655","article-title":"Myocardin-related transcription factor A mediates OxLDL-induced endothelial injury","volume":"108","author":"Fang","year":"2011","journal-title":"Circ Res"},{"issue":"35","key":"10.1016\/j.clinre.2016.11.010_bib0210","doi-asserted-by":"crossref","first-page":"25708","DOI":"10.1074\/jbc.M701925200","article-title":"A novel role of Brg1 in the regulation of SRF\/MRTFA-dependent smooth muscle-specific gene expression","volume":"282","author":"Zhang","year":"2007","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.clinre.2016.11.010_bib0215","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1161\/CIRCRESAHA.107.164178","article-title":"The histone demethylase, Jmjd1a, interacts with the myocardin factors to regulate SMC differentiation marker gene expression","volume":"101","author":"Lockman","year":"2007","journal-title":"Circ Res"},{"issue":"34","key":"10.1016\/j.clinre.2016.11.010_bib0220","doi-asserted-by":"crossref","first-page":"23125","DOI":"10.1074\/jbc.M109.019059","article-title":"Mechanical regulation of the proangiogenic factor CCN1\/CYR61 gene requires the combined activities of MRTF-A and CREB-binding protein histone acetyltransferase","volume":"284","author":"Hanna","year":"2009","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.clinre.2016.11.010_bib0225","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1093\/nar\/gkt311","article-title":"Megakaryocytic leukemia 1 (MKL1) ties the epigenetic machinery to hypoxia-induced transactivation of endothelin-1","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.clinre.2016.11.010_bib0230","doi-asserted-by":"crossref","first-page":"e89016","DOI":"10.1371\/journal.pone.0089016","article-title":"RPEL proteins are the molecular targets for CCG-1423, an inhibitor of Rho signaling","volume":"9","author":"Hayashi","year":"2014","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.clinre.2016.11.010_bib0235","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cell.2013.12.035","article-title":"Redox modification of nuclear actin by MICAL-2 regulates SRF signaling","volume":"156","author":"Lundquist","year":"2014","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.clinre.2016.11.010_bib0240","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S0102-86502012000800013","article-title":"Review of experimental models for inducing hepatic cirrhosis by bile duct ligation and carbon tetrachloride injection","volume":"27","author":"Marques","year":"2012","journal-title":"Acta Cir Bras"},{"issue":"9","key":"10.1016\/j.clinre.2016.11.010_bib0245","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/cm.20472","article-title":"Rho-kinase\/ROCK: a key regulator of the cytoskeleton and cell polarity","volume":"67","author":"Amano","year":"2010","journal-title":"Cytoskeleton (Hoboken, NJ)"},{"issue":"5","key":"10.1016\/j.clinre.2016.11.010_bib0250","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2217\/fca.11.51","article-title":"Rho kinase as a therapeutic target in cardiovascular disease","volume":"7","author":"Surma","year":"2011","journal-title":"Future Cardiol"},{"issue":"1","key":"10.1016\/j.clinre.2016.11.010_bib0255","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1164\/ajrccm.163.1.2001089","article-title":"Contribution of small GTPase Rho and its target protein rock in a murine model of lung fibrosis","volume":"163","author":"Shimizu","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.clinre.2016.11.010_bib0260","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0b013e31822b7352","article-title":"Wound contraction is attenuated by fasudil inhibition of Rho-associated kinase","volume":"128","author":"Bond","year":"2011","journal-title":"Plast Reconstr Surg"},{"issue":"7","key":"10.1016\/j.clinre.2016.11.010_bib0265","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/bjo.2010.194571","article-title":"Enhancement of corneal endothelium wound healing by Rho-associated kinase (ROCK) inhibitor eye drops","volume":"95","author":"Okumura","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.clinre.2016.11.010_bib0270","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00018-009-0189-x","article-title":"Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity","volume":"67","author":"Hahmann","year":"2010","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.clinre.2016.11.010_bib0275","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(02)02929-1","article-title":"Cardiovascular effects of Y-27632, a selective Rho-associated kinase inhibitor, assessed in the halothane-anesthetized canine model","volume":"460","author":"Takahara","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"23","key":"10.1016\/j.clinre.2016.11.010_bib0280","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2016.11.010_bib0285","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/gast.2002.31040","article-title":"5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes","volume":"122","author":"Graupera","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.clinre.2016.11.010_bib0290","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jhep.2015.12.003","article-title":"Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats","volume":"64","author":"Cerini","year":"2016","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.clinre.2016.11.010_bib0295","doi-asserted-by":"crossref","first-page":"G301","DOI":"10.1152\/ajpgi.00010.2015","article-title":"Metformin reduces hepatic resistance and portal pressure in cirrhotic rats","volume":"309","author":"Tripathi","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1016\/j.clinre.2016.11.010_bib0300","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bmcl.2009.11.056","article-title":"Design, synthesis and prostate cancer cell-based studies of analogs of the Rho\/MKL1 transcriptional pathway inhibitor, CCG-1423","volume":"20","author":"Evelyn","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"issue":"13","key":"10.1016\/j.clinre.2016.11.010_bib0305","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1016\/j.bmcl.2013.04.080","article-title":"Optimization of novel nipecotic bis(amide) inhibitors of the Rho\/MKL1\/SRF transcriptional pathway as potential anti-metastasis agents","volume":"23","author":"Bell","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.clinre.2016.11.010_bib0310","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jhep.2014.07.029","article-title":"Myocardin related transcription factor A programs epigenetic activation of hepatic stellate cells","volume":"62","author":"Tian","year":"2015","journal-title":"J Hepatol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740116302030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740116302030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:24:52Z","timestamp":1761895492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740116302030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S2210740116302030"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2016.11.010","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrahepatic upregulation of MRTF-A signaling contributes to increased hepatic vascular resistance in cirrhotic rats with portal hypertension","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2016.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}